Stockscreener 앱 받기
21.80
1.54%
0.33
시간 외 거래:
21.80
Enliven Therapeutics Inc 주식(ELVN)의 최신 뉴스
Enliven Therapeutics (NASDAQ:ELVN) Shares Gap DownHere's Why - MarketBeat
(ELVN) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Enliven Therapeutics, Inc. (NASDAQ:ELVN) COO Sells $146,207.31 in Stock - MarketBeat
Enliven Therapeutics COO Anish Patel sells $146,205 in stock - MSN
Benjamin Hohl Sells 1,000 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stock - MarketBeat
Enliven Therapeutics CFO sells $22,524 in stock - MSN
Enliven Therapeutics COO Anish Patel sells $146,205 in stock By Investing.com - Investing.com South Africa
Enliven Therapeutics CFO Sells 1,000 Shares - TradingView
Trend Tracker for (ELVN) - Stock Traders Daily
Enliven Therapeutics: Promising Innovations in Tyrosine Kinase Inhibitors and Strategic Growth Plans Justify Buy Rating - TipRanks
SG Americas Securities LLC Increases Stake in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
Strong Buy Recommendation for Enliven Therapeutics Due to ELVN-001’s High Selectivity and Promising Clinical Data - TipRanks
Enliven Therapeutics, Inc. (NASDAQ:ELVN) CFO Benjamin Hohl Sells 3,250 Shares - MarketBeat
Enliven Therapeutics CFO sells $70,177 in stock - MSN
Enliven Therapeutics (NASDAQ:ELVN) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Enliven Therapeutics (NASDAQ:ELVN) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Objective long/short (ELVN) Report - Stock Traders Daily
Enliven Therapeutics (NASDAQ:ELVN) Shares Up 11.3%Here's Why - MarketBeat
Enliven Therapeutics (NASDAQ:ELVN) Sees Strong Trading VolumeStill a Buy? - MarketBeat
Barclays PLC Acquires 42,012 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
Enliven Therapeutics, Inc. (NASDAQ:ELVN) COO Sells $524,706.00 in Stock - MarketBeat
Anish Patel, COO of Enliven Therapeutics, sells $685,868 in stock By Investing.com - Investing.com Nigeria
Anish Patel, COO of Enliven Therapeutics, sells $685,868 in stock - Investing.com
Enliven Therapeutics (NASDAQ:ELVN) Trading Down 9.8%Time to Sell? - MarketBeat
Enliven Therapeutics, Inc. (NASDAQ:ELVN) CFO Benjamin Hohl Sells 1,000 Shares - MarketBeat
Enliven's Early Data Stands Out From Peers (NASDAQ:ELVN) - Seeking Alpha
Enliven Therapeutics (ELVN) Price Target Increased by 10.75% to 35.02 - MSN
(ELVN) Trading Advice - Stock Traders Daily
Jane Street Group LLC Sells 22,212 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
Jane Street Group LLC Cuts Stock Position in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - MarketBeat
Enliven Therapeutics (NASDAQ:ELVN) Shares Up 7.6%Here's What Happened - MarketBeat
Enliven Therapeutics Inc (NASDAQ: ELVN) Stock Forecast: Bearish Sentiment Points To -75.56% Downside In 2025 - Stocks Register
Enliven Therapeutics CFO sells shares worth $94,474 - Investing.com India
Insider Selling: Enliven Therapeutics, Inc. (NASDAQ:ELVN) CFO Sells 3,350 Shares of Stock - MarketBeat
Franklin Resources Inc. Invests $559,000 in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
Barclays PLC Has $1.44 Million Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - MarketBeat
Barclays PLC Has $1.44 Million Position in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
Geode Capital Management LLC Boosts Stake in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
Geode Capital Management LLC Purchases 67,813 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - MarketBeat
0.27%
3.05%
자본화:
|
볼륨(24시간):